Delivery Order SPE2DB20D3101-SPE2DB25FRUS7
- Not listed
- The Defense Logistics Agency awarded a $1,023.75 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose on June 2, 2025, with an ultimate completion date of June 3, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed in Conshohocken, Pennsylvania. The order represents a delivery against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,373.84 for Cefazolin 1 GM vials on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a child contract under the company's larger...
- The Defense Logistics Agency awarded a $1,638.08 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Cefazolin 2G/50ML-Dextroses, an antibiotic medication in intravenous form. The contract employs firm fixed price terms with an ultimate completion date of September 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor,...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- The Defense Logistics Agency awarded a delivery order valued at $2,457.12 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This competitively awarded contract utilizes firm fixed-price terms with an ultimate completion date of September 9, 2025. The contract is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.56 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2G/50ML in dextrose solution, with an ultimate completion date of August 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Cefazolin 1 G/50 ML-Dextroses with a ceiling value of $6,334.87. This contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,228.56 on August 27, 2025, for the supply of Cefazolin 2G/50ML with dextrose solution. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,612.07 to AmerisourceBergen Drug Corp for the supply of Cefazolin 2 G/50 ML with Dextroses, an antibiotic pharmaceutical product. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and utilizes firm fixed pricing. The contract was competitively awarded with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, which serves as the vendor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Cefazolin 2G/50ML with dextrose solutions. This firm fixed-price delivery order, valued at $4,095.20, represents a competitively awarded contract with an ultimate completion date of June 2, 2025. The award was issued to the Corporate Office division of AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUS7Delivery Order
The Defense Logistics Agency awarded a $1,048.48 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2 G/50 ML-Dextrose on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company serves as a prime vendor for comprehensive pharmaceutical and medical supply distribution to federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a broad portfolio of medications and medical commodities to support military and veteran healthcare needs. The company's DLA Troop Support Medical contract serves as a global pharmaceutical support vehicle enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. This competitive award demonstrates AmerisourceBergen's capability to fulfill federal procurement requirements and reflects its role as a critical vendor within the Defense Health Agency's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/8/25 |